A method of preparing a compound of the formula: ##STR1## where Formula (I) may also have the structure of partial Formula (III); wherein, ##STR2## R' is hydrogen or methyl; R" is hydrogen or .beta.-methyl; R'" is .beta.-methyl or hydroxy; Z is (1) oxo; (2) .beta.-hydrogen and .alpha.-hydroxy; or .alpha.-hydrogen or .alpha.-hydroxyl and (3) (Y).sub.n Q where n=0 or 1, Y is a straight or branched hydrocarbon chain of 1 to 12 carbon atoms and Q is ##STR3## where R.sup.8 is, ##STR4## where the dashed bond replaces the 17.alpha. hydrogen; (6) cyano; or (7) tetrazolyl; and pharmaceutically acceptable salts of the above compounds; CHARACTERIZED IN THAT (I.) a compound of the formula: ##STR5## , where A has the meanings above except --CH.dbd.CH--, is (1) treated with an oxidizing agent at reduced temperatures to form the corresponding 5-oxo-3,5-seco-androstan-3-oic acid compound; (2) treating the product of step (1) with an amine of formula: R.sup.1 NH.sub.2 to form the corresponding 4-aza-5-androsten-3-one compound substituted in the 4-position with R.sup.1 ; and (3) treating the product of step (2) with hydrogen under catalytic conditions to form the compound of Formula I and I & II wherein B is ##STR6## (II.) and where it is desired to prepare compounds of Formula I wherein B is ##STR7## additionally carrying out the following steps on the products prepared by the procedures in (I.) above: (1) alkylating the lactim carbonyl by treating it with trialkyloxonium tetrafluoroborate to form the corresponding alkyl iminium ether, i.e., the compound of Formula I where B is as above and R.sup.4 =OR.sup.5 ; (2) treating the product of step (1) with an amine of formula HNR.sup.6 R.sup.7 followed by treatment with a mineral acid to form the compound of Formula I where B is as above and R.sup.4 =NR.sup.6 R.sup.7 ; (III.) and where it is desired to prepare compounds of Formula I wherein A is --CH.dbd.CH--, additionally carrying out the following steps on the products prepared by the procedures in (I.) above: (1) treating the 1,2 saturated compound with lithium diisopropyl amide to form the corresponding enolate; (2) treating the enolate of step (1) in situ with diphenyldisulfide to form the corresponding .alpha.-phenylthio compound; (3) oxidizing the product of step (2) to form the corresponding sulfoxide compound; and (4) heating the product of step (3) to form the compound of Formula I wherein A is --CH.dbd.CH--.
将公式为:##STR1##的化合物制备方法翻译成中文:其中,公式(I)也可能具有部分公式(III)的结构;其中,##STR2## R'为氢或甲基;R"为氢或β-甲基;R'"为β-甲基或羟基;Z为(1)氧代;(2)β-氢和α-羟基;或α-氢或α-羟基和(3)(Y).sub.n Q,其中n=0或1,Y为1至12个碳原子的直链或支链烃链,Q为##STR3##,其中R.sup.8为,##STR4##,其中虚线键替代17α氢;(6)
氰基;或(7)
四唑基;以及上述化合物的药用盐;其特征在于(I.)公式为:##STR5##的化合物,其中A具有上述含义,除了--CH.dbd.CH--,经过以下步骤:(1)在较低温度下用氧化剂处理,形成相应的5-氧代-3,5-
戊二烯基雄烷-3-酸化合物;(2)用式为R.sup.1 NH.sub.2的胺处理步骤(1)的产物,形成在4位用R.sup.1取代的相应的4-氮杂-5-雄烷-3-酮化合物;(3)用催化条件下的氢处理步骤(2)的产物,形成公式I和I & II的化合物,其中B为##STR6##(II.)并且如果希望制备B为##STR7##的公式I的化合物,另外对(I.)中的程序制备的产物进行以下步骤:(1)通过用三烷氧
氟硼酸盐处理酮内酰基,烷基化,形成相应的烷基
亚胺醚,即B为上述和R.sup.4 =OR.sup.5的公式I化合物;(2)用式为HNR.sup.6 R.sup.7的胺处理步骤(1)的产物,然后用矿酸处理,形成B为上述和R.sup.4 =NR.sup.6 R.sup.7的公式I化合物;(III.)并且如果希望制备A为--CH.dbd.CH--的公式I的化合物,另外对(I.)中的程序制备的产物进行以下步骤:(1)用异丙基
二异丙胺处理1,2饱和化合物,形成相应的烯醇负离子;(2)用二苯基二
硫处理步骤(1)的烯醇负离子,形成相应的α-苯
硫化合物;(3)氧化步骤(2)的产物,形成相应的亚砜化合物;(4)加热步骤(3)的产物,形成A为--CH.dbd.CH--的公式I化合物。